Completed

Evaluation of Store-and-Forward Teledermatology Versus a Face-to-Face Assessment During a Skin Cancer Screening Event

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being tested

In-person dermatology evaluation

+ Store-and-forward teledermatology evaluation

Other
Who is being recruted

Neoplasms+2

+ Neoplasms by Site

+ Skin Diseases

Over 18 Years
+6 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Screening Study

Interventional
Study Start: September 2010
See protocol details

Summary

Principal SponsorUniversity of California, Davis
Last updated: July 19, 2017
Sourced from a government-validated database.Claim as a partner

Study start date: September 1, 2010

Actual date on which the first participant was enrolled.

The purpose of this study is to determine the diagnostic and management concordance of face-to-face dermatologist versus a store-and-forward teledermatologist at a skin cancer screening event. The investigators' hypotheses include the following: Compared to in-person assessment, store-and-forward teledermatology assessment will result in adequate diagnostic concordance. Compared to in-person assessment, store-and-forward teledermatology results in adequate management concordance. The sensitivity and specificity of store-and-forward evaluation to detecting lesions that are either premalignant or malignant will be similar to that of in-person evaluation.

NCT01820234
Principal SponsorUniversity of California, Davis
Last updated: July 19, 2017
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

170 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Screening Study

Screening studies test new methods to find diseases or risk factors early—before any symptoms appear. This helps catch health issues sooner, when they may be easier to treat.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

Over 18 Years

Range of ages for which participants are eligible to join.

Healthy volunteers allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

NeoplasmsNeoplasms by SiteSkin DiseasesSkin and Connective Tissue DiseasesSkin Neoplasms

Criteria

4 inclusion criteria required to participate
18 years of age or older at time of consent, may be male or female
Able to provide a brief medical history and have/allow an examination of their skin including photographs
Capable of giving informed consent
Will be able to receive notification of follow-up recommendations
2 exclusion criteria prevent from participating
Patient who are unable to fulfill tasks of this study
Patients who will not provide informed consent

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Treatment Groups
Study Objectives

2 intervention groups are designated in this study

This study does not include a placebo group 

Treatment Groups

Group I

Health care modality

Group II

Health care modality

Study Objectives

Primary Objectives

Secondary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

University of California, Davis Shifa Community Clinic

Sacramento, United StatesOpen University of California, Davis Shifa Community Clinic in Google Maps
CompletedOne Study Center